微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 12.36% | -26.73% | 19.08% | 16/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 10.38% | -6.91% | 88.73% | 6/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 5.5% | -24.76% | -73.33% | 6/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 20.62% | -7.12% | 22.23% | 2/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 16.87% | -13.49% | 51.3% | 3/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 11.15% | -12.14% | 52.53% | 2/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 7.31% | 9.1% | -67.07% | 2/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 22.2% | 30.97% | 13.85% | 5/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 19.5% | 27.95% | 53.66% | 3/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 12.69% | 18.49% | 89.4% | 6/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 6.7% | 23.39% | -60.47% | 2/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.95% | 16.98% | 11.22% | 15/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 15.24% | 23.6% | 42.3% | 11/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.71% | 50.63% | 97.24% | 13/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.43% | 92.55% | -62.53% | 8/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 14.49% | 25.67% | 17.52% | 33/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 12.33% | 33.73% | 73.42% | 27/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 7.11% | 33.4% | 152.13% | 36/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.82% | 89.26% | -75.54% | 37/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.53% | 18.87% | 25.05% | 50/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 9.22% | 2.22% | 72.98% | 40/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.33% | -32.53% | 257.72% | 45/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.49% | -68.89% | -84.64% | 71/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 9.7% | -43.64% | 7.54% | 52/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.02% | -42.29% | 14.18% | 30/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.9% | -26.85% | 64.93% | 17/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.79% | -26.53% | -72.17% | 12/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 17.21% | 5.07% | 10.11% | 18/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 15.63% | 15.44% | 44.72% | 11/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 10.8% | 20.54% | 65.64% | 13/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 6.52% | 57.49% | -60.2% | 3/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 16.38% | 19.3% | 20.97% | 34/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 13.54% | 63.33% | 51.12% | 14/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 8.96% | 42.22% | 116.43% | 20/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.14% | -3.94% | -69.85% | 17/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 13.73% | -38.24% | 65.62% | 38/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 8.29% | -50.12% | 31.59% | 33/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 6.3% | -32.33% | 46.17% | 29/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.31% | -29.8% | -80.61% | 16/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |